NORTHERN TRUST CORP - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 41 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$952,000
-30.8%
4,139,924
+7.8%
0.00%
Q4 2021$1,375,000
-29.8%
3,839,725
+17.9%
0.00%
Q3 2021$1,958,000
-43.2%
3,257,565
+4.8%
0.00%
-100.0%
Q2 2021$3,450,000
+324.4%
3,108,226
+389.1%
0.00%
Q1 2021$813,000
+356.7%
635,539
+141.7%
0.00%
Q4 2020$178,000
-15.6%
262,985
+4.8%
0.00%
Q3 2020$211,000
+486.1%
250,858
+327.4%
0.00%
Q2 2020$36,000
+89.5%
58,699
+119.7%
0.00%
Q1 2020$19,00026,7160.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2020
NameSharesValueWeighting ↓
Virtu Financial LLC 734,477$441,0000.04%
GSA CAPITAL PARTNERS LLP 516,218$310,0000.03%
Game Plan Financial Advisors, LLC 27,216$16,0000.01%
MONECO Advisors, LLC 35,000$21,0000.01%
Purus Wealth Management, LLC 15,000$9,0000.01%
Renaissance Technologies 6,038,664$3,630,0000.01%
Qube Research & Technologies Ltd 540,878$325,0000.00%
D. E. Shaw & Co., Inc. 6,690,867$4,022,0000.00%
Cutter & CO Brokerage, Inc. 19,000$11,0000.00%
Van Hulzen Asset Management, LLC 18,200$11,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders